Summary: At its Investor Day on October 1, Harmony Biosciences presented a pipeline update, highlighting progress in its sleep disorder treatments. New data from the orexin-2 agonist BP1.15205 showed potential best-in-class potency, while long-term extension data for pitolisant … [Read more...]
BMC Medical Highlights Telemedicine and AI in Sleep Care at ERS Congress
Summary: At the European Respiratory Society Congress, BMC Medical Co highlighted its PAP Link telemedicine solution and new advancements in sleep and respiratory healthcare, focusing on how AI and digital health can enhance patient outcomes and improve the efficiency of positive … [Read more...]
Vanda Highlights Q2 Efforts to Expand Hetlioz Amid Regulatory and Market Challenges
Summary: Vanda Pharmaceuticals reported its second-quarter 2024 financial and operational results, emphasizing efforts to expand the use of Hetlioz (tasimelteon) for pediatric insomnia and jet lag disorder. The company notes its financial performance was impacted by generic … [Read more...]
Zevra Highlights Plans to Advance IH, Narcolepsy Drug Candidate
Summary: Zevra Therapeutics Inc., in its yr-conclude fiscal and corporate update for 2023, highlighted the development of KP1077 in dealing with idiopathic hypersomnia, citing promising Stage 2 analyze final results. The organization also introduced designs to existing new info … [Read more...]